Literature DB >> 11927279

Translating basic cancer research into new cancer therapeutics.

Paul Workman1, Stanley B Kaye.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11927279     DOI： 10.1016/s1471-4914(02)02319-5

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


× No keyword cloud information.
  12 in total

1.  Apoptosis in cancer: archaeology, functional relevance and exploitation in novel treatment strategies.

Authors:  E F Gaffney
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

2.  Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors.

Authors:  Manoj Kumar; Sean P Arlauckas; Sona Saksena; Gaurav Verma; Ranjit Ittyerah; Stephen Pickup; Anatoliy V Popov; Edward J Delikatny; Harish Poptani
Journal:  Mol Cancer Ther       Date:  2015-02-05       Impact factor: 6.261

Review 3.  Beyond chemotherapy: targeted therapies in ovarian cancer.

Authors:  Timothy A Yap; Craig P Carden; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

4.  Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.

Authors:  Sean L Petersen; Lai Wang; Asligul Yalcin-Chin; Lin Li; Michael Peyton; John Minna; Patrick Harran; Xiaodong Wang
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

5.  Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses.

Authors:  W M Liu; D W Fowler; P Smith; A G Dalgleish
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

6.  The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis.

Authors:  Qing Zhang; Xinguo Chen; Yunjin Zang; Li Zhang; Hong Chen; Letian Wang; Yujian Niu; Xiuyun Ren; Zhongyang Shen; Lei Shang
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Tyrosine kinase - Role and significance in Cancer.

Authors:  Manash K Paul; Anup K Mukhopadhyay
Journal:  Int J Med Sci       Date:  2004-06-01       Impact factor: 3.738

8.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

Authors:  M O Leach; K M Brindle; J L Evelhoch; J R Griffiths; M R Horsman; A Jackson; G C Jayson; I R Judson; M V Knopp; R J Maxwell; D McIntyre; A R Padhani; P Price; R Rathbone; G J Rustin; P S Tofts; G M Tozer; W Vennart; J C Waterton; S R Williams; P Workman
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

Review 9.  Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.

Authors:  M Beloueche-Babari; Y-L Chung; N M S Al-Saffar; M Falck-Miniotis; M O Leach
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

10.  Finding the needle in the haystack: why high-throughput screening is good for your health.

Authors:  G Wynne Aherne; Edward McDonald; Paul Workman
Journal:  Breast Cancer Res       Date:  2002-06-10       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.